|
|||||
|
|
Rituximab/Bendamustine treatment of chronic lymphatic leukemia leads to sustained remission of antiphospholipid antibodies |
|
| Authors: | Paul RJ Ames Mira Merashli Fabrizio Gentile |
| Abstract: | |
| Keywords: | Antiphospholipid Bendamustine Plasma cells Rituximab SLE |